Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Celltrion (068270) – (Correction) Provisional Consolidated Financial Results / 2026-07-27

Posted on July 27, 2026August 5, 2026 By K-STOCK Editor No Comments on [Disclosure] Celltrion (068270) – (Correction) Provisional Consolidated Financial Results / 2026-07-27

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion has issued a correction to its Q2 2026 provisional financial results. Compared to the initial disclosure, the Q2 consolidated revenue has been revised upward to KRW 1.3937T and operating profit to KRW 451.8B.

📊 [Summary of Key Disclosure Content & Major Figures]

  • Filing Date: July 27, 2026
  • Initial Filing Date: July 3, 2026
  • Reason for Correction: Revisions to provisional consolidated financial results for Q2 2026

[Corrections in Q2 2026 Provisional Results (Consolidated KRW)]

  • Revenue (Q2 2026): Revised from KRW 1.3000T to KRW 1.3937T (+21.72% QoQ, +44.95% YoY)
  • Cumulative Revenue (H1 2026): Revised from KRW 2.4450T to KRW 2.5387T (+40.77% YoY)
  • Operating Profit (Q2 2026): Revised from KRW 430.0B to KRW 451.8B (+40.35% QoQ, +86.31% YoY)
  • Cumulative Operating Profit (H1 2026): Revised from KRW 751.9B to KRW 773.7B (+97.42% YoY)

[Detailed Corrected Q2 2026 Financial Results (Consolidated)]

  • Profit Before Income Tax: Q2 consolidated KRW 457.8B (+5.92% QoQ, +773.66% YoY) / H1 cumulative KRW 890.0B
  • Net Profit: Q2 consolidated KRW 371.3B (+6.15% QoQ, +486.57% YoY) / H1 cumulative KRW 721.2B
  • Net Profit Attributable to Owners of Parent: Q2 consolidated KRW 370.2B (+6.96% QoQ, +504.90% YoY) / H1 cumulative KRW 716.3B

[Related Prior Filings]

  • 2026-07-03: Provisional Consolidated Financial Results

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Finalized Financial Figures Following External Auditor Review

This disclosure represents a correction to previously published provisional results based on internal accounting, with both revenue and operating profit adjusted upward. Verifying whether any discrepancies arise between these preliminary figures and the final numbers determined following external auditor accounting review is essential for accurately understanding the company’s ultimate financial performance. Finalized figures can be verified in the financial statements section of upcoming periodic reports, such as the Q2 2026 quarterly report.

📢 Disclaimer & Source Notice

Source: This content has been structured and newly created based on official regulatory data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided strictly for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) – Provisional Performance (Consolidated Financial Results) / 2026-07-27
Next Post: [Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2026-07-29

Related Posts

[Disclosure] Hanwha Systems (272210) Announces Institutional IR Event for Q4 2024 Financial Results Disclosures
[Disclosure] Hanwha Ocean (042660) to List 54,495 New Common Shares via Third-Party Allocation, Issuance Price at KRW 40,350 Disclosures
[Disclosure] ISU PETASYS(007660) – Additional Listing (Rights Offering) / 2025-04-28 Semiconductors
[Disclosure] SK hynix(000660) – Report on Reason for Holding Shareholders’ Meeting on Concentrated Date / 2024-03-06 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Modification of Listing (Stock Retirement) / 2024-05-16 Semiconductors
[Disclosure] SK Square (402340) – Modification of Listing (Retirement of Shares) / 2024-04-18 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme